Avalon Globocare Corp (NASDAQ: ALBT) is a technology company that operates two early-stage business segments: a consumer health technology segment distributing the Keto Air breathalyzer device, and an artificial intelligence content technology segment developing an AI-driven short-form video generation platform through its wholly owned subsidiary Avalon Quantum AI, LLC. Revenue to date has been minimal across both segments. The Keto Air device, a non-invasive handheld breathalyzer that measures ketosis levels via exhaled acetone, carries an FDA registration number and is sold through the KetoAir website and social media in North America. The AI content platform was acquired via the December 15, 2025 all-stock purchase of RPM Interactive, Inc. for a stated price of $19.5 million, paid in Series E Non-Voting Convertible Preferred Stock. The company has not generated sustainable revenue since inception and reported a net loss from continuing operations of approximately $17.5 million for the year ended December 31, 2025. It is also pursuing bolt-on AI acquisitions and holds early-stage patent applications developed in collaboration with MIT.

Revenue model

Transactional product sales of the Keto Air breathalyzer device through direct-to-consumer online channels. The RPM AI platform has not yet generated meaningful revenue as of the 10-K filed March 30, 2026. The company disclosed it anticipates approximately one year from the filing date before generating meaningful revenue from the RPM platform.

Products and services

Keto Air breathalyzer: a non-invasive consumer device measuring ketosis levels via exhaled acetone, bearing an FDA registration number, distributed under rights from Qi Diagnostics for North America, South America, the EU, and the UK. RPM platform (operated by Avalon Quantum AI, LLC): an AI-driven short-form video and podcast generation platform with an AI avatar feature that replicates a content creator's voice and likeness. Early-stage patent applications co-developed with MIT using the QTY code protein design platform, and a patent application related to CAR-T cellular therapy technologies.

Customers and end markets

Consumer health end market targeting diabetes and obesity patients and individuals monitoring ketosis. AI content technology end market targeting content creators seeking AI-generated video and audio content. The company has not yet developed a meaningful customer base as of the 10-K filed March 30, 2026.

Value-chain role

Distributor and direct-to-consumer retailer for the Keto Air device. Developer and commercializer of an AI content generation platform. Early-stage IP holder for biotech-adjacent patents filed with MIT and related to CAR-T therapy.

Geographic exposure

Primary sales and operations in North America. Keto Air distribution rights cover North America, South America, the EU, and the UK. The RPM platform may implicate EU AI Act obligations for users located outside the United States.

Source: SEC 10-K, filed 2026-03-30

Industry: Services-Computer Programming Services Peers: Capital Properties Inc Wave Sync Corp. DigitalBridge Group Inc LUXURBAN HOTELS INC. InterGroup Corp J W Mays Inc Rafael Holdings Inc Trinity Place Holdings Inc